Skip to main content
. 2021 Jun 22;11(36):22057–22069. doi: 10.1039/d1ra03770f
F127
K (M−1) graphic file with name d1ra03770f-t19.jpg graphic file with name d1ra03770f-t20.jpg graphic file with name d1ra03770f-t21.jpg
Cytarabine
298.15 (1.6 ± 0.1) × 103 −(1.0 ± 0.1) (58.1 ± 1.2) −(18.3 ± 0.4)
303.15 (2.9 ± 0.1) × 103 −(0.9 ± 0.1) (63.2 ± 1.3) −(20.1 ± 0.4)
308.15 (3.7 ± 0.1) × 103 −(0.7 ± 0.1) (66.1 ± 1.3) −(21.1 ± 0.4)
313.15 (4.8 ± 0.2) × 103 −(0.4 ± 0.1) (69.3 ± 1.4) −(22.1 ± 0.4)
Gemcitabine
298.15 (3.3 ± 0.7) × 104 (1.3 ± 0.2) 91.2 ± 1.8 −(25.8 ± 0.5)
303.15 (4.0 ± 0.1) × 104 (1.5 ± 0.3) 92.8 ± 1.3 −(27.6 ± 0.4)
308.15 (6.0 ± 1.0) × 104 (1.6 ± 0.3) 96.9 ± 1.9 −(28.2 ± 0.5)
313.15 (1.0 ± 0.2) × 105 (1.9 ± 0.3) 101.9 ± 2.0 −(30.1 ± 0.6)
Hydroxyurea
298.15 (1.7 ± 0.3) × 103 −(1.1 ± 0.2) 58.1 ± 1.0 −(18.4 ± 0.4)
303.15 (2.7 ± 0.5) × 103 −(1.2 ± 0.2) 61.9 ± 1.2 −(19.9 ± 0.4)
308.15 (4.5 ± 0.9) × 103 −(1.4 ± 0.3) 65.5 ± 1.3 −(21.6 ± 0.4)
313.15 (7.8 ± 1.6) × 103 −(1.7 ± 0.3) 69.2 ± 1.4 −(23.3 ± 0.5)